Finance

Lists
PROK:NASDAQ
ProKidney Corp
$1.06
+1.92%
(+0.020) 1D
$1.06
0.00% (0.00)
After hours
Closed: Nov 19, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PROK...
Open
$1.07
High
$1.13
Low
$1.02
Mkt. cap
320.52M
Avg. vol.
1.40M
Volume
1.65M
52-wk high
$2.65
52-wk low
$0.87
EPS
-$0.60
Beta
1.88
Shares outstanding
209.63M
No. of employees
231
Open
$1.07
High
$1.13
Low
$1.02
Mkt. cap
320.52M
Avg. vol.
1.40M
Volume
1.65M
52-wk high
$2.65
52-wk low
$0.87
EPS
-$0.60
Beta
1.88
Shares outstanding
209.63M
No. of employees
231
News stories
From web sources and news partners
About ProKidney Corp
CEO-
Employees231
Founded2015
HeadquartersWinston-Salem, North Carolina, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to PROK in the past 3 months
Buy
Buy
2
Hold
0
Sell
1
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PROK in the last 3 months.
Highest
Current $1.06
$12.00 (+1,032.08%)
Average
$10.00 (+843.40%)
Lowest
$8.00 (+654.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dina Ramadane
Bank of America Securities
Sell
Maintained
-
-
11/13/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$12.00
+1,032.1%
11/13/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$8.00
+654.7%
10/28/2026
Anupam Rama
J.P. Morgan
Hold
Maintained
-
-
08/13/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
$3.00
+183%
08/11/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$7.00
+560.4%
08/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
225.00K
226.00K
150.00K
174.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
34.16M
33.84M
36.10M
40.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.76M
11.32M
12.43M
13.09M
Operating expense
45.91M
45.16M
48.52M
53.93M
Total operating expenses
45.91M
45.16M
48.52M
53.93M
Operating income
-45.69M
-44.93M
-48.37M
-53.76M
Other non operating income
-
-
-
-
EBT including unusual items
-42.44M
-42.62M
-46.44M
-52.23M
EBT excluding unusual items
-42.76M
-42.62M
-46.44M
-52.23M
Income tax expense
-1.58M
-
-
-436.00K
Effective tax rate
3.73%
-
-
0.83%
Other operating expenses
-
-
-
-
Net income
-19.23M
-20.04M
-28.42M
-35.59M
Net profit margin
-8,547.11%
-8,865.93%
-18,948.00%
-20,455.17%
Earnings per share
-0.14
-0.14
-0.15
-0.17
Interest and investment income
2.94M
2.33M
1.94M
1.53M
Interest expense
-1.00K
-15.00K
-1.00K
-1.00K
Net interest expenses
2.93M
2.31M
1.94M
1.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.85M
-43.28M
-46.70M
-52.08M
Gain or loss from assets sale
957.00K
-
-
50.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps